9 December 2015 - The Transparency Commission will consider the reimbursement of alirocumab (Praluent) for patients with hypercholesterolaemia and a new ...
27 November 2015 - The Transparency Commission will consider the reimbursement of nivolumab (Opdivo) for patients with non small cell ...
17 November 2015 - The Transparency Commission wiill consider submission for the following medicines: Jinarc (tolvaptan), Otezla (apremilast), Menotrophine (human ...
30 October 2015 - The TC will have its first look at Repatha (evolocumab) at the upcoming November 4 meeting. ...
19 October 2015 - The agenda for the 21 October 2015 TC meeting is now available. The Commission will consider the ...
4 October 2015 - The agenda for the 7 October 2015 TC meeting is now available. The Commission considered the following ...
26 September 2015 - The agenda for the 23 September 2015 TC meeting is now available. The Commission considered the following ...
9 September 2015 - The agenda for the 16 September 2015 TC meeting is now available. The Commission will consider the ...
The agenda for the 17 June 2015 TC meeting is now available. The Commission will consider the following technologies: ...
Pharmaceutical companies are pushing back against decisions by cash-strapped European governments to reimburse patients for drugs that haven't been approved ...
France has negotiated a big discount for Gilead Sciences Inc's controversial new hepatitis C drug Sovaldi, under a government deal that ensures it ...
The agenda for the 17 September 2014 Transparency Commission is now available. The Commission will consider the following new medicines and new ...
The agenda for the 4 February 2015 Transparency Commission meeting is now available. The Commission will consider the following medicines: ...
The agenda for the 5 November 2014 Transparency Commission is now available. The Commission will consider the listing of the ...